Antisense modulation of PTP1B expression

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6261840
SERIAL NO

09487368

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antisense compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • IONIS PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cowsert, Lex M Carlsbad, CA 219 3577
Wyatt, Jacqueline Encinitas, CA 75 695

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation